Grazoprevir
Back to searchMolecule Structure
Scientific Name
Grazoprevir
Description of the Drug
Grazoprevir is an antiviral and NS3/4A protease inhibitor used to treat hepatitis C infections.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB11575
http://www.drugbank.ca/drugs/DB11575
Brand Name(s)
Not Available
Company Owner(s)
Merck Sharp And Dohme Llc A Sub Of Merck And Co Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Hepatitis C virus serine protease, NS3/NS4A | PROTEIN COMPLEX | INHIBITOR | CHEMBL2095231 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL2175313 | |
PharmGKB | PA166163437 | |
DrugBank | DB11575 | |
PubChem: Thomson Pharma | 163501421 | |
PubChem | 44603531 | |
LINCS | LSM-45592 | |
Nikkaji | J3.213.950G | |
PDBe | SUE | |
BindingDB | 50485492 | |
EPA CompTox Dashboard | DTXSID50159234 | |
DrugCentral | 5081 | |
Brenda | 239747 | 236443 |
rxnorm | GRAZOPREVIR | GRAZOPREVIR ANHYDROUS |
ChEBI | 132975 | |
ZINC | ZINC000095551509 |